Squarepoint Ops LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1.95 Million - $2.28 Million	1,900 Added 13.87%	15,600 $16.4 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $5.03 Million - $6.11 Million	-5,700 Reduced 29.38%	13,700 $14.4 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $8.67 Million - $9.54 Million	9,600 Added 97.96%	19,400 $18.7 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $8.91 Million - $10.1 Million	-11,500 Reduced 53.99%	9,800 $8.61 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $14.5 Million - $17.2 Million	20,700 Added 3450.0%	21,300 $15.3 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $2.99 Million - $3.64 Million	-4,400 Reduced 88.0%	600 $493,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $229,588 - $289,728	-400 Reduced 7.41%	5,000 $3.44 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $164,505 - $221,652	300 Added 5.88%	5,400 $3.19 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $1.96 Million - $2.3 Million	-3,300 Reduced 39.29%	5,100 $3.56 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $271,740 - $335,485	500 Added 6.33%	8,400 $5.31 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $172,209 - $204,288	300 Added 3.95%	7,900 $4.78 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $4.07 Million - $4.8 Million	-8,600 Reduced 53.09%	7,600 $4.25 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $3.84 Million - $4.71 Million	8,600 Added 113.16%	16,200 $7.67 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $3.64 Million - $4.62 Million	7,600 New	7,600 $3.67 Million

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account